Evidence map›Paper›PMID 40895248›Full record

ArticleHealth science reports2025

The Next Frontier in Parkinson's Disease Treatment: A Narrative Review of Innovative Neurosurgical and Gene Therapy Approaches.

Muhammad Shaheer Bin Faheem, Muhammad Haroon-Ul-Rasheed, Rohma Aftab, Qasra Faheem, Faheem Feroze, Hafiza Qurat Ul Ain, Sumaya Samadi

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Muhammad Shaheer Bin FaheemDepartment of Internal Medicine Karachi Institute of Medical Sciences, KIMS Karachi Pakistan.ORCID https://orcid.org/0009-0005-6878-2031
Muhammad Haroon-Ul-RasheedCMH Multan Institute of Medical Sciences Multan Pakistan.
Rohma AftabCMH Multan Institute of Medical Sciences Multan Pakistan.
Qasra FaheemDepartment of Internal Medicine Karachi Institute of Medical Sciences, KIMS Karachi Pakistan.
Faheem FerozeCombined Military Hospital Rawalpindi, CMH Rawalpindi Pakistan.
Hafiza Qurat Ul AinCMH Multan Institute of Medical Sciences Multan Pakistan.
Sumaya SamadiKabul University of Medical Sciences "Abu Ali Ibn Sina" Kabul Afghanistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Parkinson's disease (PD) is a progressive neurological condition that consists of both motor and non-motor symptoms that considerably deteriorate the quality of life. Pharmacological treatments, primarily levodopa, have been used to manage PD. However, side effects such as dyskinesias and motor fluctuations frequently limit their long-term effectiveness. In recent decades, breakthroughs and innovations in neurosurgical treatments have transformed the entire treatment landscape. Methods: This narrative review looks at clinical research focused on neurosurgical, gene therapy, and other modern methods for treating PD. Forty-seven studies were included in the search from PubMed, while three others were taken from other databases. Results: Deep brain stimulation (DBS) is the most established neurosurgical technique, and has strong evidence that it can improve motor symptoms. Focused ultrasound (FUS) provides a noninvasive option, but the majority of studies related to it still lack long-term data. Gene therapy strategies like AAV2-hAADC and ProSavin have shown early-phase safety and efficacy, but are still in early clinical stages. Newer imaging techniques and robotic surgery can play a critical role PD-related surgery, in the future. Conclusion: The range of PD treatment options is growing because of the newer neurosurgical and gene therapy approaches. The current results are promising, but larger-scale, controlled trials are required to show long-term safety and efficacy.

Indexed as

deep brain stimulationfocused ultrasound stimulationpallidotomyParkinson's diseasethalamotomy

Identifiers

PMID40895248
PMCPMC12391019

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.